"Deoxyadenosines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.
| Descriptor ID |
D003839
|
| MeSH Number(s) |
D03.633.100.759.590.138.325 D13.570.230.229 D13.570.583.138.325
|
| Concept/Terms |
Deoxyadenosines- Deoxyadenosines
- Deoxyadenosine Derivatives
- Derivatives, Deoxyadenosine
- Adenine Deoxyribonucleosides
- Deoxyribonucleosides, Adenine
- Adenylyldeoxyribonucleosides
|
Below are MeSH descriptors whose meaning is more general than "Deoxyadenosines".
Below are MeSH descriptors whose meaning is more specific than "Deoxyadenosines".
This graph shows the total number of publications written about "Deoxyadenosines" by people in this website by year, and whether "Deoxyadenosines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Deoxyadenosines" by people in Profiles.
-
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp). Curr Med Chem. 2022; 29(1):152-162.
-
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm. Chem Biol Drug Des. 2021 04; 97(4):836-853.
-
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. J Antimicrob Chemother. 2018 10 01; 73(10):2721-2728.
-
Investigational Antiretroviral Drugs: What is Coming Down the Pipeline. Top Antivir Med. 2018 Apr; 25(4):127-132.
-
5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents. Bioorg Med Chem. 2007 Nov 15; 15(22):6882-92.